Rapid Micro Biosystems : TD Cowen 45th Annual Health Care Conference

Published: 2025-03-20 02:08:05 ET RPID

TD Cowen 45th Annual Health Care Conference

Robert Spignesi, President & CEO

March 4, 2025

R A P I D M I C R O B I O S Y S T E M S

N A S D A Q : R P I D

© 2025, Rapid Micro Biosystems, Inc. | RAPID MICRO BIOSYSTEMS® and GROWTH DIRECT® are registered trademarks of Rapid Micro Biosystems, Inc., and the company logo is a trademark of Rapid Micro Biosystems, Inc.

Our vision

We are transforming a critical, regulated part of the global pharmaceutical manufacturing process, bringing microbial quality control into

the 21st century.

The new standard in microbial quality control

Rapid Micro Biosystems

The standard in automating microbial quality control

2 0 2 4 R E V E N U E

$28M

Total Revenue

25%

Year / Year Growth

$15M

Recurring Revenue

G L O B A L S Y S T E M S

160+

Cumulative Placements

135+

Cumulative Validations

~20

Countries

C U S T O M E R S

70%

Top 20 Global Pharma1

86%

Approved CAR-T Manufacturers

Rapid Micro Biosystems

By revenue

of Rapid Micro Biosystems, Inc., and the company logo is a trademark of Rapid Micro Biosystems, Inc.

Strong and consistent revenue growth and margin improvement

R E V E N U E

Recurring

Revenue Growth Drivers

Non-recurring

$28.1M

New customer wins

•

$22.5M

• Drive global deployments at existing customers

$17.1M

• Launch new products and services

• Strong consumable and service growth

2022

2023

2024

G R O S S M A R G I N

2022

2023

2024

Gross Margin Expansion Drivers

•

Reduce product costs

•

Improve manufacturing efficiency

•

Increase service productivity

50+ percentage point improvement

Rapid Micro Biosystems

trademarks of Rapid Micro Biosystems, Inc., and the company logo is a trademark of Rapid Micro Biosystems, Inc.

2024 revenue guidance exceeded with strong fourth quarter

S E L E C T H I G H L I G H T S

Record quarterly (Q4) and full year revenue;

ninth quarter in a row exceeding / meeting revenue guidance

Over 160 cumulative Growth Direct systems now placed globally

Inflected to positive gross margins in Q3 & Q4

Announced significant collaborations with both Merck KGaA (MilliporeSigma) and with Lonza

R E S U LT S

Q 4 2 0 2 4

F Y 2 0 2 4

Total Revenue

$8.2M

$28.1M

30% growth

25% growth

Recurring Revenue

$4.2M

$15.5M

Systems Placed

Systems Validated

2025 outlook for 'at least' $32M in revenue with meaningful gross margin expansion

Rapid Micro Biosystems

Inc., and the company logo is a trademark of Rapid Micro Biosystems, Inc.

Distribution & Collaboration Agreement with Merck KGaA1

(MilliporeSigma)

Agreement Highlights

Advances and accelerates top strategic priorities

Accelerating Growth Direct system placements

Improving gross margins

Driving innovation

Rapid Micro Biosystems

1 The Life Science business of Merck KGaA, Darmstadt, Germany, operating in the U.S. as MilliporeSigma

MQC has not kept up with pharma industry innovation

Scientific and

Growing demand

F A C T O R S D R I V I N G C H A N G E

Faster & leaner

Data integrity &

Regulatory

technology

for more complex

manufacturing

security focus

scrutiny

innovation

therapies

T O D A Y

Discovery & research

High-throughput R&D automation

QC & ANALYSIS

Bioprocessing & manufacturing

Flexible single use technologies

Rapid Micro Biosystems

Challenges in a traditional microbial quality control (MQC) lab

High volume testing and mandated by regulators

Insecure and

lacking data integrity

Subjective and

prone to human error

Manual, paper-based

and slow

Rapid Micro Biosystems

Introducing the Growth Direct® platform

The only fully automated,

high-throughput and secure MQC solution…

…delivering a compelling value proposition

Proprietary

Consumables

Data &

Software

Data

Integrity

Operational Efficiency

Supports global quality regulatory compliance and improved data handling and management

Enables faster decision making by accelerating time to results by 50% or faster compared to the traditional method

Global Validation &

Support Services

THE GROWTH DIRECT® (GD) PLATFORM

Insight &

Eliminate human quality control errors,

Accuracy

preventing costly recalls and regulatory interventions

Rapid Micro Biosystems

Growth Direct® transforms and modernizes MQC

M A N U A L W O R K F L O W

1 .

2 .

P U L L Q C

F I L L O U T

T E S T F O R M

A S S A Y I N F O

9 .

1 0 .

S H I F T

P U L L

S A M P L E S

3 .

P R E P A R E S A M P L E S

1 1 .

P E R F O R M C O U N T S

4 .

L O A D

I N C U B A T O R

1 2 .

P E R F O R M D U A L - R E A D

5 .

P U L L

S A M P L E S

1 3 .

R E C O R D C O U N T S

6 .

P E R F O R M C O U N T S

1 4 .

K E Y

I N T O L I M S

7 .

R E C O R D C O U N T S

1 5 .

D I S C A R D

8 .

R E T U R N S A M P L E S

R E S U L T S

Manual & subject to error

15 steps

5-14 days to result / test Unsecured

G R O W T H D I R E C T ®

A U T O M A T E D W O R K F L O W

Prepare sample &

Automated incubation and

Results

automated loading

analysis & Data handling

Automated & accurate

2 steps

Results in half the time

Full data integrity

Rapid Micro Biosystems

Disclaimer

Rapid Micro Biosystems Inc. published this content on March 20, 2025, and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on March 20, 2025 at 06:07:42.170.